| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5960285 | Heart Rhythm | 2014 | 9 Pages |
Abstract
Treatment with an A2BAdoR antagonist at 1 week results in the improvement in cardiac function and decreased substrate for VT. The inhibition of fibrogenesis by A2BAdoR antagonists may be a new target for the prevention of adverse remodeling after MI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hao MD, PhD, Hongyan PhD, Thomas H. PhD, FHRS, Emily BS, Roger BS, Dewan PhD, Luiz MD, Jeffrey E. MD, FHRS,